← All companies

OCS

Oculis Holding AG

OCS Nasdaq Pharmaceutical Preparations EDGAR ↗

$11.99

+0.10 +0.84%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$10.52 – $34.48

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jun 25, 2026 6-K Jun 1, 2026 6-K May 14, 2026 6-K May 11, 2026 6-K Apr 21, 2026 6-K Mar 4, 2026 20-F Mar 4, 2026 6-K Mar 3, 2026 6-K Nov 10, 2025 6-K Oct 31, 2025 6-K Oct 29, 2025 6-K Oct 6, 2025 6-K Aug 21, 2025 6-K Aug 1, 2025 6-K Jun 5, 2025 6-K May 9, 2025 6-K May 8, 2025 6-K Apr 15, 2025 20-F Mar 11, 2025 6-K Mar 11, 2025 6-K Feb 14, 2025 6-K Jan 6, 2025 6-K Nov 29, 2024 6-K Nov 7, 2024 6-K Aug 27, 2024 6-K FORM 6-K Jun 10, 2024 6-K May 31, 2024 6-K May 8, 2024 6-K May 8, 2024 6-K Apr 29, 2024 6-K Apr 22, 2024 6-K Apr 11, 2024 20-F Mar 19, 2024 6-K Mar 19, 2024 6-K Feb 28, 2024 6-K Nov 15, 2023 6-K Aug 29, 2023 6-K Aug 8, 2023 6-K Jul 12, 2023 6-K Jul 6, 2023